Recently, Guangzhou Sudao Information Technology Co., Ltd. (“Ysbang.cn”) announced it had completed its series C round of financing amounting to RMB 420 million, among which the series C-1 round was led by Shunwei and followed by Green Pine Capital Partners and Elevation China Capital, and the series C-2 round was led by DCM and followed by SIG.

 

Ysbang.cn is a B2B pharmaceutical marketing platform, which works on connecting the pharmaceutical suppliers and terminal customers by combining its e-commerce platform services and SaaS services, as well as providing comprehensive services such as medicine purchasing, pre-exam training and continuing education for licensed pharmacists, medicine knowledge searching and enterprise recruitment.

 

The AnJie team led by Cai Hang and assisted by Yao Ting, Liu Chenchen and Wang Dong at Shanghai office, represented Ysbang.cn to consummate this transaction.